Effects of barium, furosemide, ouabaine and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy

Brain Res. 2002 Jan 18;925(1):18-27. doi: 10.1016/s0006-8993(01)03254-1.

Abstract

Glial cells limit local K(+)-accumulation by K(+)-uptake through different mechanisms, sensitive to Ba(2+), ouabaine, furosemide, or DIDS. Since the relative contribution of these mechanisms has not yet been determined, we studied the effects of bath-applied barium (2 mM), ouabaine (9 microM), furosemide (2 mM), and DIDS (1 mM) on ionophoretically-induced rises in [K(+)](o) in the pyramidal layer of area CA1 from normal rat slices, in the presence of glutamate receptor (Glu-R) antagonists. We also investigated the effect of barium on ionophoretically-induced tetrapropylammonium (TPA(+))-signals in order to test for barium-induced changes of the extracellular space. Finally, we repeated the barium experiment on slices from human non-sclerotic and sclerotic hippocampal specimens to assess a reduced glial capability for barium-sensitive K(+)-uptake in sclerotic tissue from epilepsy patients. In normal rat slices barium augmented ionophoretically-induced rises in [K(+)](o) by approximately 120%, also in the presence of tetrodotoxin (TTX) (by approximately 150%), but did not significantly affect the TPA(+)-signal. Ouabaine also augmented the K(+)-signal, but only by 27%. Furosemide and DIDS had negligible effects. In slices from sclerotic human hippocampus an augmentation of the K(+)-signal by barium was absent. Thus barium augments ionophoretically-induced K(+)-signals to a similar extent as previously shown for stimulus-induced signals. We suggest that glial barium-sensitive K(+)-buffer mechanisms reduce fast local rises of [K(+)](o) by at least 50%. This capability of glial cells is extremely reduced in area CA1 of slices from human sclerotic hippocampal specimens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / pharmacology*
  • Anesthetics, Local / pharmacology
  • Animals
  • Barium / pharmacology*
  • Buffers
  • Diuretics / pharmacology*
  • Enzyme Inhibitors / pharmacology*
  • Epilepsy / metabolism*
  • Epilepsy / pathology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Extracellular Space / metabolism
  • Furosemide / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Humans
  • In Vitro Techniques
  • Iontophoresis
  • Ouabain / pharmacology*
  • Potassium / metabolism
  • Quaternary Ammonium Compounds / pharmacokinetics
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Wistar
  • Sclerosis
  • Tetrodotoxin / pharmacology

Substances

  • Anesthetics, Local
  • Buffers
  • Diuretics
  • Enzyme Inhibitors
  • Excitatory Amino Acid Antagonists
  • Quaternary Ammonium Compounds
  • Quinoxalines
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • tetrapropylammonium
  • Barium
  • Tetrodotoxin
  • Ouabain
  • 2-Amino-5-phosphonovalerate
  • Furosemide
  • 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
  • Potassium